Necessity of Using Pleural Drainage Tubes After IMA Harvesting During Cardiac Surgery
1 other identifier
interventional
162
1 country
1
Brief Summary
This prospective randomized controlled trial will examine the efficacy of reducing the number of chest tubes used in the postoperative cardiac surgery patient. Typically used are three chest tubes - two in the mediastinum and one in the pleural space, if opened. The investigators propose that removal of the pleural tube will not impact the rates of clinically significant pleural effusions post cardiac surgery. Patients will be randomized into two groups - one receiving the standard three chest tubes (standard), and the other receiving only mediastinal drains (experimental). The primary outcome will be rates of post-operative pleural effusions as determined by defined interventions, including insertion of a chest tube, thoracentesis, or return to the operating room for primary evacuation of pleural effusion or hemothorax. Secondary outcomes include length of hospital stay, length of mechanical ventilation, postoperative respiratory status, and presence/size of pleural effusions, as well as readmission for pleural effusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2014
CompletedFirst Posted
Study publicly available on registry
May 28, 2014
CompletedStudy Start
First participant enrolled
August 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedMay 4, 2018
May 1, 2018
3.3 years
May 22, 2014
May 2, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Pleural Effusion
Primary outcome is rate of pleural effusions in a 6 week postoperative period of CABG.
6 weeks
Secondary Outcomes (1)
Postoperative Respiratory Status
1 week after CABG
Study Arms (2)
Standard
NO INTERVENTIONStandard treatment will be defined as current practice whereby two mediastinal chest tubes are used for drainage, as well as an additional pleural tube if the pleura is opened during surgery. As part of current standard practice, the pleural and mediastinal spaces will be suctioned during the achievement of hemostasis prior to the insertion of chest tubes.
Intervention
EXPERIMENTALThe treatment arm of the study will involve standard placement of the mediastinal tubes with the exclusion of the pleural tube.
Interventions
Eligibility Criteria
You may qualify if:
- patients must be undergoing CABG at our institution with the attempted harvest of a LIMA and/or RIMA
- pleura must be entered in order for patients to be included.
You may not qualify if:
- cardiac surgery where the pleura is not entered
- previous surgery where the pleura was entered
- other pre-existing pleural diseases or fibrosis
- Patients currently participating in other studies
- Patients presenting with emergent need for bypass
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Foothills Medical Center
Calgary, Alberta, T2N 2T9, Canada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, MMgt, HBSc
Study Record Dates
First Submitted
May 22, 2014
First Posted
May 28, 2014
Study Start
August 1, 2014
Primary Completion
November 1, 2017
Study Completion
March 1, 2018
Last Updated
May 4, 2018
Record last verified: 2018-05